Yasushi Fujimoto

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki et al. · The Lancet Neurology · 2010 · 188 citations

Medicine, Neurology, Pharmacotherapy +6

Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy

Haruhiko Banno, Masahisa Katsuno, Keisuke Suzuki et al. · Annals of Neurology · 2009 · 156 citations

Medicine, Endocrinology, Pharmacotherapy +17

Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study

Tomoko Kobayashi, Shintaro Iwama, Yoshinori Yasuda et al. · Journal for ImmunoTherapy of Cancer · 2020 · 131 citations · Full text

Life Sciences, Immunology, Oncology +17

Cervical subacute necrotizing lymphadenitis. A new clinicopathological entity

Yasushi Fujimoto · Medical Entomology and Zoology · 1972 · 121 citations

Medicine, Gynecology, Pathology +11